MENU

PTCT PTC Therapeutics Forecast, Technical & Fundamental Analysis

a developer of biopharmaceutical products

Industry Biotechnology
PTCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
PTCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

PTCT is expected to report earnings to fall 32.63% to -93 cents per share on February 25

PTC Therapeutics PTCT Stock Earnings Reports
Q4'24
Est.
$-0.94
Q3'24
Beat
by $0.12
Q2'24
Missed
by $0.17
Q1'24
Beat
by $0.09
Q4'23
Missed
by $1.92
The last earnings report on November 07 showed earnings per share of -138 cents, beating the estimate of -150 cents. With 46.35K shares outstanding, the current market capitalization sits at 3.63B.
A.I. Advisor
published General Information

General Information

a developer of biopharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
100 Corporate Court
Phone
+1 908 222-7000
Employees
1058
Web
https://www.ptcbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

PTCT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PTCT has been loosely correlated with ERAS. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if PTCT jumps, then ERAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTCT
1D Price
Change %
PTCT100%
-3.27%
ERAS - PTCT
39%
Loosely correlated
+0.38%
XNCR - PTCT
38%
Loosely correlated
+2.12%
DYN - PTCT
37%
Loosely correlated
+0.23%
ABSI - PTCT
37%
Loosely correlated
-13.05%
PLRX - PTCT
36%
Loosely correlated
+4.74%
More